Compass Therapeutics Income Statement (2022-2026) | CMPX

Income Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.85M
Operating items
Research & Development (Quarter) 6.64M10.22M8.83M12.43M9.52M11.17M8.61M13.04M13.05M16.41M12.83M13.67M13.39M
Selling, General & Administrative (Quarter) 3.07M3.11M3.10M2.97M3.25M4.72M3.63M3.54M4.91M4.65M2.99M4.32M6.91M
Operating Expenses (Quarter) 9.71M13.34M11.93M15.39M12.77M15.89M12.24M16.57M17.97M21.07M15.82M17.99M20.30M
Operating Income (Quarter) -9.71M-13.34M-11.93M-15.39M-12.77M-15.04M-12.24M-16.57M-17.97M-21.07M-15.82M-17.99M-20.30M
EBIT (Quarter) -9.71M-13.34M-11.93M-15.39M-12.77M-15.04M-12.24M-16.57M-17.97M-21.07M-15.82M-17.99M-20.30M
Non-operating items
Interest & Investment Income (Quarter) 2.06M1.96M1.98M
Other Non Operating Income (Quarter) 1.87M2.06M1.96M1.98M1.98M1.97M1.76M1.54M1.33M1.19M1.56M2.27M1.98M
Non Operating Income (Quarter) 1.87M2.06M1.96M1.98M1.98M1.97M1.76M1.54M1.33M1.19M1.56M2.27M1.98M
Net income details
EBT (Quarter) -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M-17.99M-20.30M
Profit After Tax (Quarter) -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-10.48M-15.03M-16.63M-19.88M-14.26M-15.72M-18.32M
Income from Continuing Operations (Quarter) -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M-17.99M-20.30M
Consolidated Net Income (Quarter) -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M-17.99M-20.30M
Income towards Parent Company (Quarter) -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M-17.99M-20.30M
Net Income towards Common Stockholders (Quarter) -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M-17.99M-20.30M
Additional items
EPS (Basic) (Quarter) -0.06-0.09-0.08-0.10-0.08-0.10-0.08-0.11-0.12-0.14-0.08-0.08-0.10
Shares Outstanding (Weighted Average) (Quarter) 105.19M126.38M126.73M126.84M127.03M136.61M137.10M137.59M137.38M138.24M138.26M168.78M157.69M186.40M
EBITDA (Quarter) -7.68M-11.64M-9.89M-12.95M-10.91M-13.08M-9.90M-15.31M-16.65M-19.86M-14.19M-15.71M-18.76M